Pharmacophore Model of the Quercetin Binding Site of the SIRT6 Protein

Overview

Journal J Mol Graph Model

Date 2014 Feb 5

PMID 24491483

Citations 16

Authors

S Ravichandran

N Singh

D Donnelly

M Migliore

P Johnson

C Fishwick

B T Luke

B Martin

S Maudsley

S D Fugmann

R Moaddel

Affiliations

Soon will be listed here.

Abstract

SIRT6 is a histone deacetylase that has been proposed as a potential therapeutic target for metabolic disorders and the prevention of age-associated diseases. We have previously reported on the identification of quercetin and vitexin as SIRT6 inhibitors, and studied structurally related flavonoids including luteolin, kaempferol, apigenin and naringenin. It was determined that the SIRT6 protein remained active after immobilization and that a single frontal displacement could correctly predict the functional activity of the immobilized enzyme. The previous study generated a preliminary pharmacophore for the quercetin binding site on SIRT6, containing 3 hydrogen bond donors and one hydrogen bond acceptor. In this study, we have generated a refined pharmacophore with an additional twelve quercetin analogs. The resulting model had a positive linear behavior between the experimental elution time verses the fit values obtained from the model with a correlation coefficient of 0.8456.

Citing Articles

MMP9 in pan-cancer and computational study to screen for MMP9 inhibitors.

Ai X, Wang X, Ren T, Li Z, Wu B, Li M Am J Transl Res. 2024; 16(11):7071-7086.

PMID: 39678601 PMC: 11645558. DOI: 10.62347/NXMR6806.

Mechanistic Exploration of Roxb. in Osteoarthritis: Insights from Network Pharmacology, Molecular Docking, and In Vitro Validation.

Ilyas S, Baek C, Manan A, Choi Y, Jo H, Lee D Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458926 PMC: 11510151. DOI: 10.3390/ph17101285.

Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system.

Dong Z, Yang C, Tan J, Dou C, Chen Y Genes Dis. 2023; 10(3):864-876.

PMID: 37396554 PMC: 10308074. DOI: 10.1016/j.gendis.2021.12.024.

The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

Leysen H, Walter D, Clauwaert L, Hellemans L, van Gastel J, Vasudevan L Int J Mol Sci. 2022; 23(8).

PMID: 35457203 PMC: 9027355. DOI: 10.3390/ijms23084387.

A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer's Disease, Aging, Cancer, Inflammation, and Diabetes.

Akter R, Afrose A, Rahman M, Chowdhury R, Nirzhor S, Khan R Int J Mol Sci. 2021; 22(8).

PMID: 33920726 PMC: 8073883. DOI: 10.3390/ijms22084180.

References

Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L . The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483(7388):218-21. DOI: 10.1038/nature10815. View

Pan P, Feldman J, Devries M, Dong A, Edwards A, Denu J . Structure and biochemical functions of SIRT6. J Biol Chem. 2011; 286(16):14575-87. PMC: 3077655. DOI: 10.1074/jbc.M111.218990. View

Haigis M, Sinclair D . Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol. 2010; 5:253-95. PMC: 2866163. DOI: 10.1146/annurev.pathol.4.110807.092250. View

Borra M, ONeill F, Jackson M, Marshall B, Verdin E, Foltz K . Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases. J Biol Chem. 2002; 277(15):12632-41. DOI: 10.1074/jbc.M111830200. View

Singh N, Ravichandran S, Norton D, Fugmann S, Moaddel R . Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography. Anal Biochem. 2013; 436(2):78-83. PMC: 4167792. DOI: 10.1016/j.ab.2013.01.018. View

Vaidyanathan J, Vaidyanathan T, Ravichandran S . Computer simulated screening of dentin bonding primer monomers through analysis of their chemical functions and their spatial 3D alignment. J Biomed Mater Res B Appl Biomater. 2008; 88(2):447-57. DOI: 10.1002/jbm.b.31134. View

Liu T, Vachharajani V, Yoza B, McCall C . NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem. 2012; 287(31):25758-69. PMC: 3406663. DOI: 10.1074/jbc.M112.362343. View

Cheng H, Mostoslavsky R, Saito S, Manis J, Gu Y, Patel P . Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A. 2003; 100(19):10794-9. PMC: 196882. DOI: 10.1073/pnas.1934713100. View

Rodgers J, Puigserver P . Certainly can't live without this: SIRT6. Cell Metab. 2006; 3(2):77-8. DOI: 10.1016/j.cmet.2006.01.009. View

10.

Jiang H, Khan S, Wang Y, Charron G, He B, Sebastian C . SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature. 2013; 496(7443):110-3. PMC: 3635073. DOI: 10.1038/nature12038. View

11.

Kim H, Xiao C, Wang R, Lahusen T, Xu X, Vassilopoulos A . Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010; 12(3):224-36. PMC: 2935915. DOI: 10.1016/j.cmet.2010.06.009. View

12.

Dominy Jr J, Lee Y, Jedrychowski M, Chim H, Jurczak M, Camporez J . The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell. 2012; 48(6):900-13. PMC: 3534905. DOI: 10.1016/j.molcel.2012.09.030. View

13.

van Acker F, Hageman J, Haenen G, van der Vijgh W, Bast A, Menge W . Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activity. J Med Chem. 2000; 43(20):3752-60. DOI: 10.1021/jm000951n. View

14.

Zhong L, DUrso A, Toiber D, Sebastian C, Henry R, Vadysirisack D . The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010; 140(2):280-93. PMC: 2821045. DOI: 10.1016/j.cell.2009.12.041. View

15.

Mostoslavsky R, Chua K, Lombard D, Pang W, Fischer M, Gellon L . Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006; 124(2):315-29. DOI: 10.1016/j.cell.2005.11.044. View